BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong CC, Li W, Chan B, Yu J. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers. Semin Cancer Biol 2019;55:90-105. [PMID: 29665409 DOI: 10.1016/j.semcancer.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Sun X, Lu Y, Wu J, Feng J. DNA-methylated gene markers for colorectal cancer in TCGA database. Exp Ther Med 2020;19:3042-50. [PMID: 32256791 DOI: 10.3892/etm.2020.8565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen G, Fan X, Li Y, He L, Wang S, Dai Y, Bin C, Zhou D, Lin H. Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma. Epigenetics 2020;15:684-701. [PMID: 31933413 DOI: 10.1080/15592294.2019.1709267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rong G, Fan W, Shen J. High pretreatment plasma D-dimer levels predict poor prognosis in gastrointestinal cancers: A meta-analysis. Medicine (Baltimore) 2019;98:e16520. [PMID: 31335729 DOI: 10.1097/MD.0000000000016520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Zhang H, Xu C, Shi C, Zhang J, Qian T, Wang Z, Ma R, Wu J, Jiang F, Feng J. Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis. J Transl Med 2021;19:98. [PMID: 33663522 DOI: 10.1186/s12967-021-02770-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Miao Y, Su B, Tang X, Wang J, Quan W, Chen Y, Mi D. Construction and validation of m6 A RNA methylation regulators associated prognostic model for gastrointestinal cancer. IET Syst Biol 2022. [PMID: 35174637 DOI: 10.1049/syb2.12040] [Reference Citation Analysis]
6 Xu R, Xu Q, Huang G, Yin X, Zhu J, Peng Y, Song J. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma. Biomed Res Int 2019;2019:9379864. [PMID: 31956659 DOI: 10.1155/2019/9379864] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Chen W, Tang D, Tang D, Dai Y. Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma. Cell Death Dis 2020;11:906. [PMID: 33097694 DOI: 10.1038/s41419-020-03109-1] [Reference Citation Analysis]
8 Liu H, Xie HQ, Zhao Y, Zhang W, Zhang Y. DNA methylation-mediated down-regulation of TMEM130 promotes cell migration in breast cancer. Acta Histochem 2021;123:151814. [PMID: 34763116 DOI: 10.1016/j.acthis.2021.151814] [Reference Citation Analysis]